The development of CCMs requires that endothelial cells undergo excessive growth, which occurs when they acquire oncogenic gain-of-function mutations in PIK3CA (Ren et al, 2021; Peyre et al, 2021). This evidence concerns the gene PIK3CA and cerebrocostomandibular syndrome.